Archive for: Musashi in Cancer

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.

Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis.

Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2.

Stem Cells, Cancer, and MUSASHI in Blood and Guts

Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma

Musashi signaling in stem cells and cancer

The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis

Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival

Regulation of myeloid leukaemia by the cell-fate determinant Musashi

Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia